Consistently, aberrant activation of Hh target genes such as Gli1 and PTCH1 are observed in multiple types of HCC, indicating that the Hh signaling is frequently activated in HCC [210,211]. This evidence concerns the gene PTCH1 and hepatocellular carcinoma.